Is it possible to improve neurodevelopmental abnormalities in Down syndrome?
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Down syndrome (DS) is a genetic pathology caused by the triplication of human chromosome 21. Although individuals with DS have various medical problems, intellectual disability is the most invalidating aspect of the pathology. Despite numerous efforts, the mechanisms whereby gene triplication leads to the DS phenotype have not been elucidated and there are, at present, no therapies to rescue brain developmental alterations and mental disability in individuals with DS. In this review, we focused on the major defects of the DS brain, comparing data regarding humans with DS and mouse models for DS, and therapeutic interventions attempted on animal DS models. Based on the promising results of pharmacotherapies in these models, we believe that it is possible to conclude that tools to improve brain development in DS are now almost at hand. We now know that it is possible to rescue and/or improve neurogenesis, neuron maturation, connectivity, neurodegeneration and behavior. We believe that the knowledge gained in DS mouse models provides a rational basis to start new clinical trials in infants, children and adults with DS, exploiting drugs that have proved able to rescue various facets of the DS neurologic phenotype. It is not unreasonable to consider that the results of these trials may provide a positive answer to the question: ‘Is it possible to improve brain development in DS?’.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.2.274 · Cited by 3,292
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · cited 3×
“The Ginkgo biloba special extract (EGb761; Gingko) produces neuroprotective effects in different in vivo and in vitro models and there are suggestions that Gingko has a positive impact on cognition in AD, at least at high doses (Janssen et al., 2010 ). BB is a main constituent of the terpenoids in Ginkgo leaves. Based…”
BackgroundInfluentialThe specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369
Nerve Growth Factor Signaling, Neuroprotection, and Neural Repair
Sofroniew, M. V., Howe, C. L., & Mobley, W. C. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1217 · Cited by 1,284
Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159
A mouse model for Down syndrome exhibits learning and behaviour deficits
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., & Davisson, M. T. (1995) · Nature Genetics · doi:10.1038/ng1095-177 · Cited by 913 · cited 3×
“Behavioral characterization of models with triplication of Mmu16 The Ts65Dn mouse is the best-characterized model for DS. Ts65Dn mice show signifi cant hyperactivity in the dark (Reeves et al., 1995 ) and in an open-fi eld situation (Stewart, 2007 ) compared with controls.”
BackgroundMethodp75 and Trk: A two-receptor system
Chao, M. V., & Hempstead, B. L. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93922-k · Cited by 857 · cited 1×
“…factors bind to the p75 neurotrophin receptor, each also binds to, and acts through, specifi c members of the surface tyrosine receptor kinases (TRKs): NGF to TRKA; BDNF and NT-4 to TRKB; and NT-3 to TRKC and to TRKA (Meakin and Shooter, 1992 ; Meakin et al., 1992 ; Chao and Hempstead, 1995 ).”
BackgroundAltman, J., & Bayer, S. A. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.903010304 · Cited by 819
Sairanen, M., Lucas, G., Ernfors, P., Castrén, M., & Castrén, E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3741-04.2005 · Cited by 763
Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741 · cited 2×
“Apoptotic cell death (humans) Cultured neurons from the fetal DS brain exhibit an increased occurrence of apoptosis (Busciglio and Yankner, 1995 ; Busciglio et al., 2002 ; Pelsman et al., 2003 ; Helguera et al., 2005 ).”
BackgroundChromosome 21 and Down syndrome: from genomics to pathophysiology
Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., & Deutsch, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1448 · Cited by 703 · cited 2×
“Molecular mechanisms underlying brain alterations in Down syndrome The effects of trisomy on brain phenotypes have been explained by two hypotheses: 1) the ‘ gene-dosage effect ’ hypothesis claims that DS phenotypes are determined by increased dosage of a subset of dosage-sensitive genes and of their encoded proteins…”
BackgroundFluoxetine targets early progenitor cells in the adult brain
Encinas, J. M., Vaahtokari, A., & Enikolopov, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601992103 · Cited by 637
Kaduszkiewicz, H., Zimmermann, T., Beck-Bornholdt, H.-P., & van den Bussche, H. (2005) · BMJ · doi:10.1136/bmj.331.7512.321 · Cited by 522
Serotonin and brain development: role in human developmental diseases
Whitaker-Azmitia, P. M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00615-3 · Cited by 506
Geling, A., Steiner, H., Willem, M., Bally‐Cuif, L., & Haass, C. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf124 · Cited by 497
Regulation of NMDA channel function by endogenous Ca2+-dependent phosphatase
Lieberman, D. N., & Mody, I. (1994) · Nature · doi:10.1038/369235a0 · Cited by 480 · cited 1×
“Notably, inhibition of calcineurin activity leads to increased NMDAR mean open time and opening probability (Lieberman and Mody, 1994 ), supporting the view that altered excitatory neurotransmission may arise from DSCR1 over-expression in the DS brain.”
BackgroundKleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & Mobley, W. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-04.2004 · Cited by 459 · cited 1×
“Mouse models In Ts65Dn, Ts1Cje, Ts1Rhr and Tc1 mice, while basal synaptic transmission in the DG is normal, LTP is impaired as a result of reduced activation of N-methyl-Daspartate (NMDA) receptors (Kleschevnikov et al., 2004 ; O ’ Doherty et al., 2005 ; Belichenko et al., 2007, 2009a ).”
BackgroundMucke, L. (2009) · Nature · doi:10.1038/461895a · Cited by 456
Neuroanatomy of Down’s Syndrome: A High-Resolution MRI Study
Pinter, J. D., Eliez, S., Schmitt, J. E., Capone, G. T., & Reiss, A. L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1659 · Cited by 452
An Aneuploid Mouse Strain Carrying Human Chromosome 21 with down Syndrome Phenotypes.
O'Doherty, A., Ruf, S., Mulligan, C., Hildreth, V., Errington, M. L., Cooke, S., Sesay, A., Modino, S., Vanes, L., Hernandez, D., et al. (2005) · Science · doi:10.1126/science.1114535 · Cited by 434
Sago, H., Carlson, E. J., Smith, D. J., Kilbridge, J., Rubin, E. M., Mobley, W. C., Epstein, C. J., & Huang, T.-T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6256 · Cited by 382 · cited 5×
“…genes; Ms1Ts65) (Sago et al., 2000 ) were reported and their phenotypic characterization shows similar changes to the Ts65Dn mouse, usually to a somewhat lesser degree (Sago et al., 1998, 2000 ; Olson et al., 2004b, 2007 ; Siarey et al., 2005 ; Aldridge et al., 2007 ; Belichenko et al., 2007 ).”
BackgroundInfluentialEts target genes: past, present and future
Sementchenko, V. I., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204034 · Cited by 371
Aït Yahya-Graison, E., Aubert, J., Dauphinot, L., Rivals, I., Prieur, M., Golfier, G., Rossier, J., Personnaz, L., Créau, N., Bléhaut, H., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/520000 · Cited by 338 · cited 1×
“…determined by increased dosage of a subset of dosage-sensitive genes and of their encoded proteins (Delabar et al., 1993 ; Korenberg et al., 1994 ; Ait Yahya-Graison et al., 2007 ; Lyle et al., 2009 ); and, 2) the ‘ amplifi ed developmental instability ’ hypothesis holds that Hsa21 trisomy…”
BackgroundCooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336 · cited 13×
“Neurodegeneration (mouse models) Ts65Dn mice display signs of neurodegeneration and age-related atrophy and loss of BFCNs (Granholm et al., 2000 ; Cooper et al., 2001 ; Seo and Isacson, 2005; Contestabile, 2006 ).”
BackgroundMethodInfluentialLyle, R., Béna, F., Gagos, S., Gehrig, C., Lopez, G., Schinzel, A., Lespinasse, J., Bottani, A., Dahoun, S., Taine, L., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.214 · Cited by 331
Takashima, S., Becker, L. E., Armstrong, D. L., & Chan, F. (1981) · Brain Research · doi:10.1016/0006-8993(81)90314-0 · Cited by 307
Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome
Belichenko, P. V., Masliah, E., Kleschevnikov, A. M., Villar, A. J., Epstein, C. J., Salehi, A., & Mobley, W. C. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20337 · Cited by 297 · cited 2×
“…addition to density reduction, spines of Ts65Dn mice exhibit an aberrant morphology; spines in the DG, fi eld CA1, motor, somatosensory and entorhinal cortices, and medial septum of young (21 days) and adult Ts65Dn mice have a larger volume when compared to euploid mice (Belichenko et al., 2004 ).”
BackgroundPyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study
Marin‐Padilla, M. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670105 · Cited by 285
Contestabile, A., Fila, T., Ceccarelli, C., Bonasoni, P., Bonapace, L., Santini, D., Bartesaghi, R., & Ciani, E. (2007) · Hippocampus · doi:10.1002/hipo.20308 · Cited by 281
Self-citationDendritic atrophy in children with down’s syndrome.
Becker, L. E., Armstrong, D. L., & Chan, F. (1986) · Annals of Neurology · doi:10.1002/ana.410200413 · Cited by 279
Guidi, S., Bonasoni, P., Ceccarelli, C., Santini, D., Gualtieri, F., Ciani, E., & Bartesaghi, R. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00113.x · Cited by 276 · cited 6×
“Fetuses with DS show an increased astrocyte-neuron ratio in all hippocampal structures compared with controls (Guidi et al., 2008 ).”
BackgroundInfluentialSelf-citationDiscovery and genetic localization of down syndrome cerebellar phenotypes using the Ts65Dn mouse
Baxter, L. L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.2.195 · Cited by 275
Belichenko, P. V., Wright, E. E., Belichenko, N. P., Masliah, E., Li, H. H., Mobley, W. C., & Francke, U. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.22009 · Cited by 272
Kahlem, P., Sultan, M., Herwig, R., Steinfath, M., Balzereit, D., Eppens, B., Saran, N. G., Pletcher, M. T., South, S. T., Stetten, G., et al. (2004) · Genome Research · doi:10.1101/gr.1951304 · Cited by 249 · cited 20×
“Synaptojanin, a synaptic protein thought to be involved in clathrin-mediated synaptic vesicle endocytosis, is mapped on Hsa21q22.”
BackgroundInfluentialThe neurobiologie consequences of down syndrome
Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90074-2 · Cited by 248 · cited 2×
“AD-like lesions in DS brains lead to neuronal degeneration and loss, with neurons from the cholinergic and noradrenergic systems being particularly vulnerable (Coyle et al., 1986 ).”
BackgroundCataldo, A. M., Petanceska, S., Peterhoff, C. M., Terio, N. B., Epstein, C. J., Villar, A., Carlson, E. J., Staufenbiel, M., & Nixon, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06788.2003 · Cited by 241 · cited 3×
“In particular, there is a reduced expression of the TRKBT.1 variant, a dominant, negative form of TRKB lacking the tyrosine kinase domain (Cataldo et al., 2003 ), and of the full-length TRKB (Toiber et al., 2010 ).”
BackgroundMethodDYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects
Ahn, K.-J., Jeong, H. K., Choi, H.-S., Ryoo, S.-R., Kim, Y. J., Goo, J.-S., Choi, S.-Y., Han, J.-S., Ha, I., & Song, W.-J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.006 · Cited by 220 · cited 3×
“, 2008 ) and defi cits in spatial learning (Ahn et al., 2006 ). Therefore, memantine may exert its effects on memory function in Ts65Dn mice by correcting aberrant calcium ion signaling through the NMDAR. As regulation of calcium infl ux is an acute phenomenon, this hypothesis is in line with the acute effects of mema…”
BackgroundResultLi, Z., Yu, T., Morishima, M., Pao, A., LaDuca, J., Conroy, J., Nowak, N., Matsui, S.-I., Shiraishi, I., & Yu, Y. E. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm086 · Cited by 218
Carlesimo, G. A., Marotta, L., & Vicari, S. (1997) · Neuropsychologia · doi:10.1016/s0028-3932(96)00055-3 · Cited by 211 · cited 1×
“Children with DS have normal learning ability for tasks requiring implicit memory but exhibit selective impairment of explicit memory, with poor information encoding, impaired retrieval abilities and attention defi cits (Carlesimo et al., 1997 ; Vicari et al., 2000 ).”
BackgroundBahn, S., Mimmack, M., Ryan, M., Caldwell, M. A., Jauniaux, E., Starkey, M., Svendsen, C. N., & Emson, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07497-4 · Cited by 211
Development of the superior temporal neocortex is anomalous in trisomy 21
Golden, J. A., & Hyman, B. T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00011 · Cited by 210
Global up-regulation of chromosome 21 gene expression in the developing down syndrome brain
Mao, R., Zielke, C. L., Ronald Zielke, H., & Pevsner, J. (2003) · Genomics · doi:10.1016/s0888-7543(03)00035-1 · Cited by 207
Down's dyndrome and Alzheimer's disease: dendritic spine counts in the hippocampus
Ferrer, I., & Gullotta, F. (1990) · Acta Neuropathologica · doi:10.1007/bf00294247 · Cited by 201
Down's syndrome: Is there a decreased population of neurons?
Ross, M. H., Galaburda, A. M., & Kemper, T. L. (1984) · Neurology · doi:10.1212/wnl.34.7.909 · Cited by 191
Suetsugu, M., & Mehraein, P. (1980) · Acta Neuropathologica · doi:10.1007/bf00688755 · Cited by 190
Bianchi, P., Ciani, E., Guidi, S., Trazzi, S., Felice, D., Grossi, G., Fernandez, M., Giuliani, A., Calza, L., & Bartesaghi, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0534-10.2010 · Cited by 188 · cited 10×
“…TrkB.T1 prevents neurons from taking advantage of the trophic support provided by BDNF. Ts65Dn mice exhibit reduced BDNF levels in the hippocampus at 15 days and 3 months of age (Fukuda et al., 2010 ; Bianchi et al., 2010b ) but not any older (Bimonte-Nelson et al., 2003 ; Pollonini et al., 2008 ).”
BackgroundMethodInfluentialSelf-citationGuimera, J., Casas, C., Estivill, X., & Pritchard, M. (1999) · Genomics · doi:10.1006/geno.1999.5775 · Cited by 186 · cited 1×
“…is to establish a correlation between the functions of triplicated genes and the anatomo-functional phenotypes of DS. Trisomic genes and neurogenesis impairment DYRK1A is located within the DS critical region (Song et al., 1996 ) and is over-expressed in the DS brain (Guimera et al., 1999 ).”
BackgroundVoronov, S. V., Frere, S. G., Giovedi, S., Pollina, E. A., Borel, C., Zhang, H., Schmidt, C., Akeson, E. C., Wenk, M. R., Cimasoni, L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803756105 · Cited by 174 · cited 4×
“Learning defi cits were shown in transgenic mice overexpressing synaptojanin 1 ( Synj1 ; Voronov et al., 2008 ), but the learning defi cits of Ts65Dn mice were more severe.”
BackgroundMethodInfluentialYang, E. J., Ahn, Y. S., & Chung, K. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104091200 · Cited by 172
Presenilin-Dependent -Secretase-Mediated Control of p53-Associated Cell Death in Alzheimer's Disease
Alves da Costa, C., Sunyach, C., Pardossi-Piquard, R., Sevalle, J., Vincent, B., Boyer, N., Kawarai, T., Girardot, N., St. George-Hyslop, P., & Checler, F. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0651-06.2006 · Cited by 168
Martı́nez-Cué, C., Baamonde, C., Lumbreras, M., Paz, J., Davisson, M. T., Schmidt, C., Dierssen, M., & Flórez, J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00026-8 · Cited by 166
Guidi, S., Ciani, E., Bonasoni, P., Santini, D., & Bartesaghi, R. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00459.x · Cited by 165 · cited 4×
“In trisomic fetuses, we also found a defective neurogenesis in the EGL of the cerebellum, and in a region of the fi fth lobe that is the remnant of the cerebellar VZ (Guidi et al., 2011a ).”
BackgroundInfluentialSelf-citationOlson, L. E., Roper, R. J., Baxter, L. L., Carlson, E. J., Epstein, C. J., & Reeves, R. H. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20079 · Cited by 165 · cited 14×
“Similarly to Ts65Dn mice, Ts1Cje mice have a reduced cerebellar volume (Olson et al., 2004b ).”
BackgroundInfluentialClinical Potential of Minocycline for Neurodegenerative Disorders
BLUM, D., CHTARTO, A., TENENBAUM, L., BROTCHI, J., & LEVIVIER, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.012 · Cited by 157
Grossberg, G., & Thomas, S. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s6666 · Cited by 151
Hippocampal hypocellularity in the Ts65Dn mouse originates early in development
Lorenzi, H. A., & Reeves, R. H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.022 · Cited by 145
Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of down syndrome.
Belichenko, P. V., Kleschevnikov, A. M., Masliah, E., Wu, C., Takimoto‐Kimura, R., Salehi, A., & Mobley, W. C. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21895 · Cited by 141 · cited 12×
“In brain and hippocampal homogenates of neonate and 4-month-old Ts65Dn mice, the glutamate NMDA receptor (NMDAR) subunit NR1 and the AMPAR subunits GluR1, GluR2 and GluR3 are similar to controls (Pollonini et al., 2008 ).”
BackgroundMethodInfluentialDendritic and histochemical development and ageing in patients with Down's syndrome
TAKASHIMA, S., IIDA, K., MITO, T., & ARIMA, M. (1994) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1994.tb00394.x · Cited by 126
Ayberk Kurt, M., Ilker Kafa, M., Dierssen, M., & Ceri Davies, D. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.075 · Cited by 126
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
Stack, E. C., Smith, K. M., Ryu, H., Cormier, K., Chen, M., Hagerty, S. W., Del Signore, S. J., Cudkowicz, M. E., Friedlander, R. M., & Ferrante, R. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.11.002 · Cited by 114
Dynamin is a minibrain kinase/dual specificity Yak1-related kinase 1A substrate
Chen-Hwang, M.-C., Chen, H.-R., Elzinga, M., & Hwang, Y.-W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111101200 · Cited by 106 · cited 1×
“Moreover, Dyrk1a may modulate dendrite development by regulating vesicle traffi cking which is dependent on Dynamin1 (Hammerle et al., 2003 ), a GTPase putative substrate of Dyrk1a that plays a fundamental role in neurite outgrowth (Chen-Hwang et al., 2002 ).”
BackgroundSchwartz, N., Schohl, A., & Ruthazer, E. S. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.007 · Cited by 94
ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons
Helguera, P., Pelsman, A., Pigino, G., Wolvetang, E., Head, E., & Busciglio, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5107-04.2005 · Cited by 88 · cited 1×
“Apoptotic cell death (humans) Cultured neurons from the fetal DS brain exhibit an increased occurrence of apoptosis (Busciglio and Yankner, 1995 ; Busciglio et al., 2002 ; Pelsman et al., 2003 ; Helguera et al., 2005 ).”
BackgroundPérez-Cremades, D., Hernández, S., Blasco-Ibáñez, J. M., Crespo, C., Nacher, J., & Varea, E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0376-9 · Cited by 85 · cited 2×
“An increase in the number of GABAergic interneurons has been found in the somatosensory cortex of 4 – 5- month-old Ts65Dn mice (Perez-Cremades et al., 2010 ), suggesting an absolute increase in the number of inhibitory synapses.”
BackgroundBhattacharyya, A., McMillan, E., Chen, S. I., Wallace, K., & Svendsen, C. N. (2009) · Developmental Neuroscience · doi:10.1159/000236899 · Cited by 79
Ginkgo biloba in Alzheimer’s disease: A systematic review
Janßen, I. M., Sturtz, S., Skipka, G., Zentner, A., Garrido, M. V., & Busse, R. (2010) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-010-0844-8 · Cited by 78
Koo, B. K. K., Blaser, S., Harwood-Nash, D., Becker, L. E., & Murphy, E. G. (1992) · Journal of Child Neurology · doi:10.1177/088307389200700417 · Cited by 59 · cited 1×
“Defective biochemical composition of myelin and a delay in myelin formation (Banik et al., 1975 ; Shah, 1979 ; Wisniewski and Schmidt-Sidor, 1989 ; Becker et al., 1991 ; Koo et al., 1992 ) may also play a role.”
Background
Cited by
Neurogenesis impairment: An early developmental defect in Down syndrome
Stagni, F., Giacomini, A., Emili, M., Guidi, S., & Bartesaghi, R. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.026 · Cited by 120
“density (see [183]) which also contributes to the impairment of signal processing.”
Self-citationGarcía-Cerro, S., Martínez, P., Vidal, V., Corrales, A., Flórez, J., Vidal, R., Rueda, N., Arbonés, M. L., & Martínez-Cué, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106572 · Cited by 104
García-Cerro, S., Rueda, N., Vidal, V., Lantigua, S., & Martínez-Cué, C. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.06.010 · Cited by 100
Global DNA Hypermethylation in Down Syndrome Placenta
Jin, S., Lee, Y. K., Lim, Y. C., Zheng, Z., Lin, X. M., Ng, D. P. Y., Holbrook, J. D., Law, H. Y., Kwek, K. Y. C., Yeo, G. S. H., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003515 · Cited by 99
“Hopefully, a better understanding of the molecular and cellular abnormalities associated with DS may lead to new therapies for the sequela of DS, such as cognitive and developmental defects [46,47].”
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Tramutola, A., Lanzillotta, C., Di Domenico, F., Head, E., Butterfield, D. A., Perluigi, M., & Barone, E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104772 · Cited by 73
Metadata
- Authors
- Bartesaghi, R., Guidi, S., & Ciani, E.
- Venue
- revneuro
- Publisher
- Walter de Gruyter GmbH
- Published
- 2011-08-01
- Volume
- 22
- Issue
- 4
- Pages
- 419-455
- ISSN
- 0334-1763 (ISSN-L)
- 2191-0200
- OpenAlex
- W1992834359
- Cited by
- 75
- References
- 69
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.